The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS

Simple item page
dc.contributor.authorGedik, Kader Cetin
dc.contributor.authorLamot, Lovro
dc.contributor.authorRomano, Micol
dc.contributor.authorDemirkaya, Erkan
dc.contributor.authorPiskin, David
dc.contributor.authorTorreggiani, Sofia
dc.contributor.authorAdang, Laura A.
dc.contributor.authorArmangue, Thais
dc.contributor.authorBarchus, Kathe
dc.contributor.authorCordova, Devon R.
dc.contributor.authorCrow, Yanick J.
dc.contributor.authorDale, Russell C.
dc.contributor.authorDurrant, Karen L.
dc.contributor.authorEleftheriou, Despina
dc.contributor.authorFazzi, Elisa M.
dc.contributor.authorGattorno, Marco
dc.contributor.authorGavazzi, Francesco
dc.contributor.authorHanson, Eric P.
dc.contributor.authorLee-Kirsch, Min Ae
dc.contributor.authorMontealegre Sanchez, Gina A.
dc.contributor.authorNeven, Bénédicte
dc.contributor.authorOrcesi, Simona
dc.contributor.authorOzen, Seza
dc.contributor.authorPoli, Cecilia
dc.contributor.authorSchumacher, Elliot
dc.contributor.authorTonduti, Davide
dc.contributor.authorUss, Katsiaryna
dc.contributor.authorAletaha, Daniel
dc.contributor.authorFeldman, Brian M.
dc.contributor.authorVanderver, Adeline
dc.contributor.authorBrogan, Paul A.
dc.contributor.authorGoldbach-Mansky, Raphaela
dc.date.accessioned2022-04-07T16:47:09Z
dc.date.available2022-04-07T16:47:09Z
dc.date.issued2022
dc.description.abstractObjective.Autoinflammatory type I interferonopathies, chronic atypical neutrophilic dermatosis with lipodystrophyand elevated temperature/proteasome-associated autoinflammatory syndrome (CANDLE/PRAAS), stimulator of inter-feron genes (STING)–associated vasculopathy with onset in infancy (SAVI), and Aicardi-Goutières syndrome (AGS) arerare and clinically complex immunodysregulatory diseases. With emerging knowledge of genetic causes and targetedtreatments, a Task Force was charged with the development of“points to consider”to improve diagnosis, treatment,and long-term monitoring of patients with these rare diseases.Methods.Members of a Task Force consisting of rheumatologists, neurologists, an immunologist, geneticists,patient advocates, and an allied health care professional formulated research questions for a systematic literaturereview. Then, based on literature, Delphi questionnaires, and consensus methodology,“points to consider”to guidepatient management were developed.Results.The Task Force devised consensus and evidence-based guidance of 4 overarching principles and17 points to consider regarding the diagnosis, treatment, and long-term monitoring of patients with the autoinflamma-tory interferonopathies, CANDLE/PRAAS, SAVI, and AGS.Conclusion.These points to consider represent state-of-the-art knowledge to guide diagnostic evaluation, treat-ment, and management of patients with CANDLE/PRAAS, SAVI, and AGS and aim to standardize and improve care,quality of life, and disease outcomes.es
dc.description.versionVersión Publicadaes
dc.identifier.citationCetin Gedik K, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S, Adang LA, Armangue T, Barchus K, Cordova DR, Crow YJ, Dale RC, Durrant KL, Eleftheriou D, Fazzi EM, Gattorno M, Gavazzi F, Hanson EP, Lee-Kirsch MA, Montealegre Sanchez GA, Neven B, Orcesi S, Ozen S, Poli MC, Schumacher E, Tonduti D, Uss K, Aletaha D, Feldman BM, Vanderver A, Brogan PA, Goldbach-Mansky R. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS. Arthritis Rheumatol. 2022 Mar 21. doi: 10.1002/art.42087.es
dc.identifier.urihttps://doi.org/10.1002/art.42087es
dc.identifier.urihttp://hdl.handle.net/11447/5955
dc.language.isoenes
dc.subjectAutoinflammatory Type I Interferonopathieses
dc.subjectDiagnosis and Managementes
dc.titleThe 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGSes
dc.typeArticlees
dcterms.accessRightsAcceso abierto
dcterms.sourceArthritis & Rheumatologyes

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
202203_The 2021 European Alliance of Associations for Rheumatology_American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies_ CANDLE_PRAAS, S (1).pdf
Size:
10.3 MB
Format:
Adobe Portable Document Format
Description:
Texto completo
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services